| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/11/2012 | US8329729 Quinuclidine derivatives as muscarinic M3 receptor antagonists |
| 12/11/2012 | US8329728 Synthesis and anti-proliferative effect of substituted imidazo[4,5-c]pyridine compounds |
| 12/11/2012 | US8329727 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment |
| 12/11/2012 | US8329726 Inhibitors of VEGF receptor and HGF receptor signaling |
| 12/11/2012 | US8329725 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 12/11/2012 | US8329724 Process for the manufacture of pharmaceutically active compounds |
| 12/11/2012 | US8329723 1-aryl- or 1-heteroaryl-pyrido[B]indoles and uses thereof in treating cancers |
| 12/11/2012 | US8329722 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 |
| 12/11/2012 | US8329721 Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods |
| 12/11/2012 | US8329720 Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties |
| 12/11/2012 | US8329719 Neuroprotective agents for the prevention and treatment of neurodegenerative diseases |
| 12/11/2012 | US8329718 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 12/11/2012 | US8329717 Pyrimidine derivatives and their use for controlling undesired plant growth |
| 12/11/2012 | US8329716 Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors |
| 12/11/2012 | US8329715 Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors |
| 12/11/2012 | US8329714 Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer |
| 12/11/2012 | US8329713 Fused ring heterocycles as potassium channel modulators |
| 12/11/2012 | US8329712 Heterocyclic antiviral compounds |
| 12/11/2012 | US8329711 Pyridone-substituted-dihydropyrazolopyrimidinone derivative |
| 12/11/2012 | US8329710 Metformin folate and preparation of the same |
| 12/11/2012 | US8329709 5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors |
| 12/11/2012 | US8329707 Substituted pyrazine compounds |
| 12/11/2012 | US8329706 Oxazolidinone derivatives |
| 12/11/2012 | US8329705 Substituted triazolo-pyrazine compounds |
| 12/11/2012 | US8329704 Substituted pyrazinone derivatives for use in MCH-1 mediated diseases |
| 12/11/2012 | US8329703 Pyrazole compounds |
| 12/11/2012 | US8329702 Heterocycles useful as modulators of ion channels |
| 12/11/2012 | US8329701 Dihydrofuro pyrimidines as AKT protein kinase inhibitors |
| 12/11/2012 | US8329700 Pyrazine compounds as phosphodiesterase 10 inhibitors |
| 12/11/2012 | US8329699 Pyrrolopyrazine kinase inhibitors |
| 12/11/2012 | US8329698 Quinoxalinedione derivatives which are activators of AMPK-activated protein kinase |
| 12/11/2012 | US8329697 Imidizo[1,2-A]pyrazines useful as AHCY hydrolase inhibitors |
| 12/11/2012 | US8329696 Solid state forms of sitagliptin salts |
| 12/11/2012 | US8329695 Crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide |
| 12/11/2012 | US8329694 Quinoxalinones as antibacterial composition |
| 12/11/2012 | US8329693 Method for the prevention of thromboembolic disorders |
| 12/11/2012 | US8329692 Pyrimidinyl pyridazinone derivatives |
| 12/11/2012 | US8329691 Amide compounds and use of the same |
| 12/11/2012 | US8329690 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 12/11/2012 | US8329689 Substituted indoles and a method for the production and use thereof |
| 12/11/2012 | US8329688 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid |
| 12/11/2012 | US8329687 Pyridooxazepine derivative and use thereof |
| 12/11/2012 | US8329686 Isatin analogues and uses therefor |
| 12/11/2012 | US8329685 Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances |
| 12/11/2012 | US8329684 Cephalosporin derivatives and pharmaceutical compositions thereof |
| 12/11/2012 | US8329683 Treatment of neurofibromatosis with radicicol and its derivatives |
| 12/11/2012 | US8329682 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof |
| 12/11/2012 | US8329681 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals |
| 12/11/2012 | US8329680 Formulation |
| 12/11/2012 | US8329679 Preformulation for tabletting natural mixtures of conjugated estrogens |
| 12/11/2012 | US8329678 Antiinflammatory compound |
| 12/11/2012 | US8329677 Method of treating and preventing secondary hyperparathyroidism |
| 12/11/2012 | US8329676 Cycloalkane-containing sphingosine 1-phosphate agonists |
| 12/11/2012 | US8329675 Inhibitors of fatty acid amide hydrolase |
| 12/11/2012 | US8329674 Film forming dental compositions and related methods |
| 12/11/2012 | US8329673 Alkylated semi synthetic glycosaminoglycosan ethers, and methods for making and using thereof |
| 12/11/2012 | US8329672 Oral and/or topical compositions comprising prebiotics and fatty acid |
| 12/11/2012 | US8329670 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron |
| 12/11/2012 | US8329669 Composition and method for treatment of tumors |
| 12/11/2012 | US8329666 Compositions and methods for treating cancer |
| 12/11/2012 | US8329665 Compositions and methods for treating cancer |
| 12/11/2012 | US8329664 Anti-viral pyrimidine nucleoside derivatives |
| 12/11/2012 | US8329663 Compositions and methods for the treatment of chronic infections |
| 12/11/2012 | US8329656 Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders |
| 12/11/2012 | US8329647 Method of treating a subject according to biomarkers for insulin resistance |
| 12/11/2012 | US8329641 Antiischemic agents; anticholesterol agents; cardiovascular disorders; using granulocyte colony stimulating agents |
| 12/11/2012 | US8329638 Antibacterial agent based on fatty acid esters of hydroxy carboxylic acids |
| 12/11/2012 | US8329637 Immunosuppression and antigen-specific immune tolerance; allogenic organ rejection, graft versus host disease, type I diabetes, rheumatoid arthritis, multiple sclerosis, systemic lupus erithematosus; chronic inflammatory disease; Crohn's disease and ulcerative colitis; asthma |
| 12/11/2012 | US8329619 Substituted quinolinones having herbicidal action |
| 12/11/2012 | US8329463 RNA interference mediating small RNA molecules |
| 12/11/2012 | US8329227 Compositions for improving mental performance |
| 12/11/2012 | US8329220 Controlled release formulations |
| 12/11/2012 | US8329216 Oxymorphone controlled release formulations |
| 12/11/2012 | US8329215 Shell and core dosage form approaching zero-order drug release |
| 12/11/2012 | US8329214 Process for producing fenofibrate tablets |
| 12/11/2012 | US8329212 Abuse potential reduction in abusable substance dosage form |
| 12/11/2012 | US8329208 Pharmacokinetics of S-adenosylmethionine formulations |
| 12/11/2012 | US8329207 Compositions and methods for the sustained release of beta-alanine |
| 12/11/2012 | US8329200 Cosmetic or dermatological stick |
| 12/11/2012 | US8329197 Ex vivo uses of immunostimulatory combinations |
| 12/11/2012 | US8329190 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 12/11/2012 | US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 12/11/2012 | US8329179 Death domain containing receptor 4 antibodies and methods |
| 12/11/2012 | US8329159 Hepatitis C virus inhibitors |
| 12/11/2012 | US8329158 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
| 12/11/2012 | US8329157 Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
| 12/11/2012 | US8329156 Ionomeric silicone thermoplastic elastomers |
| 12/11/2012 | US8329155 Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof |
| 12/11/2012 | US8329150 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 12/11/2012 | US8329149 Topical lightening composition and uses thereof |
| 12/11/2012 | US8329147 Alkyl benzoate mixtures |
| 12/11/2012 | US8329070 Liposomal apparatus and manufacturing method |
| 12/11/2012 | CA2721440C Crystalline (6r,7r)-7-{2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-[(z)-trityloxyimino]-acetylamino}-3-[(r)-1'-tert-butoxycarbonyl-2-oxo-[1,3']bipyrrolidinyl-(3e)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use |
| 12/11/2012 | CA2710464C Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof |
| 12/11/2012 | CA2698221C Compositions comprising quinolone and methods for treating or controlling infections |
| 12/11/2012 | CA2652048C Method and compositions for treating hematological malignancies |
| 12/11/2012 | CA2650202C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 12/11/2012 | CA2648852C Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases |
| 12/11/2012 | CA2647819C Phenylcyclohexyl derivatives as dgat1 inhibitors |
| 12/11/2012 | CA2620374C Pharmaceutical compositions for the treatment of inner ear disorders |